Showing 21 - 40 of 123 results
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.
The Australian Critical Minerals Research and Development Hub (the Hub) unites the expertise of top Federal science agencies: ANSTO, Geoscience Australia, and CSIRO with the aim of addressing technical challenges and drive collaborative research across the critical minerals value chain.
ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.
ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.
The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.
See details of previously published customer updates from our Health products team.
ANSTO provides eduroam services for partnering institutions in Australia and around the world.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Awards and prizes granted at the User Meeting 2020 for scientists.
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
Ongoing media statements relating to nuclear medicine production.